122 related articles for article (PubMed ID: 23458271)
21. [Molecular pathology of Charcot-Marie-Tooth disease type 1A: abnormal expression of PMP-22].
Yoshikawa H; Nishimura T; Yanagihara T
Rinsho Shinkeigaku; 1995 Dec; 35(12):1441-3. PubMed ID: 8752424
[TBL] [Abstract][Full Text] [Related]
22. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
23. Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy.
Ravera S; Nobbio L; Visigalli D; Bartolucci M; Calzia D; Fiorese F; Mancardi G; Schenone A; Morelli A; Panfoli I
J Neurochem; 2013 Jul; 126(1):82-92. PubMed ID: 23578247
[TBL] [Abstract][Full Text] [Related]
24. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
25. Unmyelinated nerve fiber degeneration in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; Van den Berg LH; Dieks HJ; Plante E; Veldman H; Franssen H; Wokke JH
Acta Neuropathol; 2000 May; 99(5):571-8. PubMed ID: 10805103
[TBL] [Abstract][Full Text] [Related]
26. Skin Biopsy Findings in Patients With CMT1A: Baseline Data From the CLN-PXT3003-01 Study Provide New Insights Into the Pathophysiology of the Disorder.
Duchesne M; Danigo A; Richard L; Vallat JM; Attarian S; Gonnaud PM; Lacour A; Péréon Y; Stojkovic T; Nave KA; Bertrand V; Nabirotchkin S; Cohen D; Demiot C; Magy L
J Neuropathol Exp Neurol; 2018 Apr; 77(4):274-281. PubMed ID: 29408953
[TBL] [Abstract][Full Text] [Related]
27. [Autopsy case of a patient with Charcot-Marie-Tooth disease type 1A and suspected chronic inflammatory demyelinating polyradiculoneuropathy, which was later diagnosed as amyotrophic lateral sclerosis].
Higuchi Y; Sakiyama Y; Nishihira Y; Endo K; Suwazono S; Suehara M
Rinsho Shinkeigaku; 2012; 52(10):750-6. PubMed ID: 23064625
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical and ultrastructural classification of peripheral neuropathies with onion-bulbs.
Chou SM
Clin Neuropathol; 1992; 11(3):109-14. PubMed ID: 1319289
[TBL] [Abstract][Full Text] [Related]
29. The importance of quantitative electron microscopy in studying hypertrophic neuropathies. A comparison between a case of Déjérine Sottas disease (HMSN III) and a case of the hypertrophic form of Charcot-Marie-Tooth disease (HMSN I).
Tredici G; Petruccioli-Pizzini MG; Gergely A; Coletti A
Int J Tissue React; 1984; 6(3):267-74. PubMed ID: 6090332
[TBL] [Abstract][Full Text] [Related]
30. CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology.
Pollard JD; Armati PJ
J Peripher Nerv Syst; 2011 Mar; 16(1):15-23. PubMed ID: 21504498
[TBL] [Abstract][Full Text] [Related]
31. Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease.
Fornasari BE; Ronchi G; Pascal D; Visigalli D; Capodivento G; Nobbio L; Perroteau I; Schenone A; Geuna S; Gambarotta G
Exp Biol Med (Maywood); 2018 Feb; 243(4):370-374. PubMed ID: 29350067
[TBL] [Abstract][Full Text] [Related]
32. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
Fortun J; Go JC; Li J; Amici SA; Dunn WA; Notterpek L
Neurobiol Dis; 2006 Apr; 22(1):153-64. PubMed ID: 16326107
[TBL] [Abstract][Full Text] [Related]
33. Modeling the Pathogenesis of Charcot-Marie-Tooth Disease Type 1A Using Patient-Specific iPSCs.
Shi L; Huang L; He R; Huang W; Wang H; Lai X; Zou Z; Sun J; Ke Q; Zheng M; Lu X; Pei Z; Su H; Xiang AP; Li W; Yao X
Stem Cell Reports; 2018 Jan; 10(1):120-133. PubMed ID: 29276154
[TBL] [Abstract][Full Text] [Related]
34. N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
Haslbeck KM; Schleicher ED; Friess U; Kirchner A; Neundörfer B; Heuss D
Acta Neuropathol; 2002 Jul; 104(1):45-52. PubMed ID: 12070663
[TBL] [Abstract][Full Text] [Related]
35. Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy.
Krendel DA; Parks HP; Anthony DC; St Clair MB; Graham DG
Muscle Nerve; 1989 Apr; 12(4):257-64. PubMed ID: 2770778
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers of CIDP in patients with diabetes or CMT1.
Latov N
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
[TBL] [Abstract][Full Text] [Related]
37. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy.
Nicolas G; Maisonobe T; Le Forestier N; Léger JM; Bouche P
Muscle Nerve; 2002 Jan; 25(1):26-30. PubMed ID: 11754181
[TBL] [Abstract][Full Text] [Related]
38. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients.
Sahenk Z; Nagaraja HN; McCracken BS; King WM; Freimer ML; Cedarbaum JM; Mendell JR
Neurology; 2005 Sep; 65(5):681-9. PubMed ID: 16157899
[TBL] [Abstract][Full Text] [Related]
39. Neurogenetics: white matter matters.
Mattson MP
Trends Neurosci; 2002 Mar; 25(3):135-6. PubMed ID: 11852141
[No Abstract] [Full Text] [Related]
40. NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.
Fledrich R; Akkermann D; Schütza V; Abdelaal TA; Hermes D; Schäffner E; Soto-Bernardini MC; Götze T; Klink A; Kusch K; Krueger M; Kungl T; Frydrychowicz C; Möbius W; Brück W; Mueller WC; Bechmann I; Sereda MW; Schwab MH; Nave KA; Stassart RM
Nat Commun; 2019 Apr; 10(1):1467. PubMed ID: 30931926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
